Systemic therapy, survival and end-of-life costs for metastatic triple-negative breast cancer: retrospective SEER-Medicare study of women age ≥65 years
出版年份 2021 全文链接
标题
Systemic therapy, survival and end-of-life costs for metastatic triple-negative breast cancer: retrospective SEER-Medicare study of women age ≥65 years
作者
关键词
-
出版物
Future Oncology
Volume -, Issue -, Pages -
出版商
Future Medicine Ltd
发表日期
2021-03-25
DOI
10.2217/fon-2021-0019
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of Immunotherapy in Triple-Negative Breast Cancer
- (2020) Tanya E. Keenan et al. Journal of the National Comprehensive Cancer Network
- Immunotherapy and targeted therapy combinations in metastatic breast cancer
- (2019) Francisco J Esteva et al. LANCET ONCOLOGY
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Overall survival, costs and healthcare resource use by number of regimens received in elderly patients with newly diagnosed metastatic triple-negative breast cancer
- (2019) Abdalla Aly et al. Future Oncology
- Immunotherapy in Older Adults with Cancer
- (2019) Richard Curtis Godby et al. Current Oncology Reports
- Update on triple‐negative breast cancer disparities for the United States: A population‐based study from the United States Cancer Statistics database, 2010 through 2014
- (2019) Lia C. Scott et al. CANCER
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States
- (2018) Kendra L. Schwartz et al. CANCER
- Differences in Breast Cancer Survival by Molecular Subtypes in the United States
- (2018) Nadia Howlader et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Using oncology real-world evidence for quality improvement and discovery: the case for ASCO's CancerLinQ
- (2018) Robert S Miller et al. Future Oncology
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune checkpoint inhibitors and elderly people: A review
- (2017) Amaury Daste et al. EUROPEAN JOURNAL OF CANCER
- Research needs in breast cancer
- (2016) F. Cardoso et al. ANNALS OF ONCOLOGY
- Comparison of SEER Treatment Data With Medicare Claims
- (2016) Anne-Michelle Noone et al. MEDICAL CARE
- Receipt of Chemotherapy Among Medicare Patients With Cancer by Type of Supplemental Insurance
- (2015) Joan L. Warren et al. JOURNAL OF CLINICAL ONCOLOGY
- Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
- (2014) M. Bonotto et al. ONCOLOGIST
- Sensitivity of Medicare Claims Data for Measuring Use of Standard Multiagent Chemotherapy Regimens
- (2012) Elizabeth B. Lamont et al. MEDICAL CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search